# Phytochemical Insights and Biological Potential of the Helianthus Genus

**Authors:** Aldana Malen Corlatti, Hernán Bach, Ignacio Jorge Agudelo, Orlando Germán Elso, Rafael Ricco, Laura Cecilia Laurella, Valeria Patricia Sülsen

PMC · DOI: 10.3390/plants15030401 · Plants · 2026-01-28

## TL;DR

This paper reviews the chemical composition and health benefits of plants in the Helianthus genus, focusing on species like sunflower and Jerusalem artichoke.

## Contribution

The paper provides a comprehensive overview of the phytochemical and biological research on Helianthus species, highlighting gaps in clinical studies.

## Key findings

- Terpenoids and phenolic compounds are the main secondary metabolites in Helianthus species.
- H. annuus has been studied for over 20 bioactivities, mostly in vitro, while H. tuberosus has fewer documented effects.
- Antidiabetic, antioxidant, antimicrobial, and anticancer properties are the most frequently reported bioactivities.

## Abstract

The Helianthus genus comprises more than 60 species distributed throughout North and Central America, with a few extending into South America. Among these, H. annuus and H. tuberosus represent the most widely utilized and extensively investigated species. The aim of this paper is to provide an overview of the current knowledge regarding the phytochemical composition and biological activities of Helianthus species. Phytochemical studies of Helianthus taxa have demonstrated that terpenoid constituents, including sesquiterpene lactones, diterpenes, and triterpenes, together with phenolic compounds, constitute the principal classes of secondary metabolites. Pharmacological investigations on Helianthus extracts have revealed a broad spectrum of biological activities. More than twenty distinct bioactivities have been reported for H. annuus, with the majority supported by in vitro assays (≈26 reports), reflecting multiple experimental evaluations per activity using different plant parts, extracts, and models; followed by a substantial number of in vivo studies in animal models (≈21 reports), and very limited clinical evidence. In comparison, five bioactivities have been described for H. tuberosus, mainly in vitro with a few in vivo reports, whereas only single in vitro bioactivities have been described for H. salicifolius and H. angustifolius. Among these, antidiabetic, antioxidant, antimicrobial, and anticancer properties are the most frequently documented.

## Linked entities

- **Species:** Helianthus (taxon 4231)

## Full-text entities

- **Chemicals:** triterpenes (MESH:D014315), phenolic compounds (-), diterpenes (MESH:D004224), terpenoid (MESH:D013729)
- **Species:** Helianthus annuus (common sunflower, species) [taxon 4232], Helianthus tuberosus (Jerusalem artichoke, species) [taxon 4233]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899590/full.md

## Figures

50 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899590/full.md

## References

131 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899590/full.md

---
Source: https://tomesphere.com/paper/PMC12899590